STAT+: GLP-1s are given an FDA warning for rare eye condition risk
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye
DO
By Daniel Okafor · Regulatory Correspondent
Nov 10 09:38 ETSource: STAT
From the source
Read at statnews.comSTAT+: GLP-1s are given an FDA warning for rare eye condition risk
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”
